Published in AIDS Weekly, June 26th, 2000
To ensure its future availability, the authors assert, we need to increase our research efforts today, including clinical trials. Although small-scale clinical trials of HIV-1 vaccines have been underway since 1987, the first Phase III efficacy trials started only recently in the USA and Thailand. Initial results from these trials will be available within the next two to three years, and we must start planning now how vaccines should be used if found to be effective, say Jose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.